- Home
- PSNY vs MANE Comparison
PSNY vs MANE Comparison
Compare PSNY & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNY | MANE |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | Sweden | United States |
| Employees | 1686 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PSNY | MANE |
|---|---|---|
| Price | $18.90 | $91.69 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $15.00 | ★ $83.33 |
| AVG Volume (30 Days) | 120.0K | ★ 416.0K |
| Earning Date | 04-17-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.06 | N/A |
| Revenue Next Year | $47.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $36.26 |
| 52 Week High | $23.75 | $117.71 |
Technical Indicators
Market Signals| Indicator | PSNY | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 43.79 |
| Support Level | $16.25 | $54.23 |
| Resistance Level | $22.68 | $107.95 |
| Average True Range (ATR) | 1.48 | 6.62 |
| MACD | -0.46 | -2.18 |
| Stochastic Oscillator | 15.48 | 0.00 |
Price Performance
Historical ComparisonAbout PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.